FDA issued a Warning Letter to Hi-Tech Pharmacal Co., Inc. on 6/28/2010 for a previous inspection.
483 Hi-Tech Pharmacal, An AKORN Company Feb 2019

483 Hi-Tech Pharmacal, An AKORN Company Feb 2019

$119 - Not in Stock

FDA investigators audited the Hi-Tech Pharmacal, An AKORN Company - Amityville, NY, United States facility and issued inspectional observations (via FDA 483) on 13 Feb 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 13 Feb 2019
  • Location: Amityville, United States
  • FEI: 2433247
Order